Tranexamic acid for osteoarthritis, knee

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Sep 2026: Trial registered, NCT07825350

The trials

NCT07825350: HTO and Tranexamic Acid Study

State
Not started
Phase
Phase 3
People
200 planned
Started
1 Jan 2027
Primary completion
1 Jan 2030
Arms
SOC + Tranexamic Acid
Results
None posted
  1. 17 Sep 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Also known as Cyclo-f, Cyklokapron, Espercil, Femstrual, Haematrix, Lysteda, Rikavarin, TRANEXAMIC ACID 1 G in 10 mL INTRAVENOUS INJECTION, SOLUTION, Transamin, Tranexamic Acid 500 MG, Tranexamic acid tablets.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.